Use of a naphthalenmethanamino derivative as antiinflammatory agent and pharmaceutical compositions containing it
申请人:SANDOZ AG
公开号:EP0385952A2
公开(公告)日:1990-09-05
The compound of formula I
in free base form or in naphthalene-1,5-disulfonate acid addition salt form is known. It has now been found to possess anti-inflammatory activity. It is thus indicated for anti-inflammatory use, especially topically. Further, water-soluble acid addition salt forms have been found which are indicated for use in the preparation of e.g. pharmaceutical compositions wherein the compound is present in dissolved state in an aqueous phase.
式 I 的化合物
是已知的游离碱形式或萘-1,5-二磺酸酸加成盐形式。现已发现它具有抗炎活性。因此,它可用于消炎,尤其是局部消炎。此外,还发现了水溶性酸加成盐形式,可用于制备药物组合物等,其中化合物以溶解状态存在于水相中。